Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,714
Total Claims
$4.4M
Drug Cost
509
Beneficiaries
$8,702
Cost/Patient
Risk Score Breakdown 40/100
Score components are additive. Read full methodology
Peer Comparison vs. 6,382 Endocrinology providers
+121%
Cost per patient vs peers
$8,702 vs $3,933 avg
-51%
Brand preference vs peers
25.2% vs 51.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.4%
Opioid Rate
210
Opioid Claims
$6,129
Opioid Cost
20.5%
Long-Acting Rate
Brand vs Generic
Brand: 3,675 claims · $3.8M
Generic: 10,901 claims · $587K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 447 | $610K |
| Denosumab | 274 | $475K |
| Dapagliflozin Propanediol | 215 | $245K |
| Empagliflozin | 196 | $229K |
| Dulaglutide | 121 | $224K |
| Icosapent Ethyl | 236 | $162K |
| Linaclotide | 180 | $151K |
| Inclisiran Sodium | 38 | $136K |
| Lipase/Protease/Amylase | 65 | $115K |
| Dapaglifloz Propaned/Metformin | 90 | $110K |
| Apixaban | 63 | $83K |
| Sitagliptin Phosphate | 77 | $75K |
| Liraglutide | 29 | $57K |
| Fluticasone/Umeclidin/Vilanter | 56 | $52K |
| Sitagliptin Phos/Metformin Hcl | 41 | $51K |
Prescribing Profile
Patient Profile
77
Avg Age
60%
Female
1.82
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About